S&P Futures
3,365.75-4.25(-0.13%)Dow Futures
27,838.00-28.00(-0.10%)Nasdaq Futures
11,106.50-19.50(-0.18%)
Cryo-Cell International, Inc. (CCEL)
Chart Events
Performance Outlook
| Previous Close | 9.25 |
| Open | 9.55 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 9.50 - 9.93 |
| 52 Week Range | 4.52 - 9.93 |
| Volume | 9,613 |
| Avg. Volume | 4,837 |
| Market Cap | 72.061M |
| Beta (5Y Monthly) | 0.08 |
| PE Ratio (TTM) | 22.16 |
| EPS (TTM) | 0.43 |
| Earnings Date | Jul 10, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- GlobeNewswire
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2020 Financial Results
OLDSMAR, Fla., July 10, 2020 -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and.
- GlobeNewswire
Cord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke University
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that effective June 9, 2020, the Company has entered into a patent option agreement with Duke University. The six-month exclusive option agreement gives Cryo-Cell an option to obtain a license to manufacture and sell products based on Dr. Joanne Kurtzberg’s patents. Please see the Company’s Form 8-K filed with the Securities and Exchange Commission on June 11, 2020 for more details.
- GlobeNewswire
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2020 Financial Results
Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 29, 2020. The revenues for the first quarter of fiscal 2020 consisted of $7.41 million in processing and storage fee revenue, $60,000 in product revenue and $154,000 in public banking revenue compared to $7.34 million in processing and storage fees, $26,000 product revenue and $134,000 in public banking revenue for the first quarter of fiscal 2019. The Company reported net income of $687,000 or $0.09 per basic common share and $0.08 per diluted common share for the three months ended February 29, 2020 compared to net income of $276,000, or $0.04 per basic common share and $0.03 per diluted common share for the same period in 2019.
